针对侵袭性皮肤状细胞癌的内部治疗方法
Gloria Baeza-Hernández1, Javier Cañueto1,2,3
1Department of Dermatology, Complejo Asistencial Universitario de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain.
Cancers
|January 11, 2024
概括
本综述探讨了皮肤状细胞癌 (cSCC) 和状细胞癌 (KA) 的内部治疗方法,涵盖了既有和新兴的疗法. 它强调了除了手术之外的其他选择来管理这些常见的皮肤癌症.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种流行的人类癌症,具有转移潜力.
- cSCC的发病率正在上升,特别是在老年人中,这对未来的健康构成了重大挑战.
- 虽然手术是标准的,但内损伤疗法为cSCC和角质腺瘤 (KA) 提供了替代治疗选择.
研究的目的:
- 审查目前和新兴的cSCC和KA的内伤病治疗模式.
- 讨论基于患者和临床因素的内伤疗法的选择标准.
- 探索未来的视角在内部损伤治疗,包括免疫疗法和瘤病毒.
主要方法:
- 对已确立的cSCC和KA的伤口内治疗方法的文献综述.
- 讨论经典的药物,如甲甲酸盐,5-甲,白素和干扰素.
- 评估冷手术,电化疗和新型/正在开发的疗法.
主要成果:
- 讨论了传统的内伤性药物 (甲索,5-甲,白素,干扰素) 和冷手术.
- 电化学疗法被提出为一种可行的内伤选择.
- 新型疗法,包括免疫疗法和瘤治疗病毒,对未来的cSCC/KA管理有希望.
结论:
- 内部治疗为精选的cSCC和KA患者提供了与手术有价值的替代方案.
- 治疗选择是个性化的,考虑患者因素和临床医生的专业知识.
- 目前正在进行的新型内伤剂和免疫疗法的研究为推进cSCC/KA治疗提供了显著的潜力.
关键词:
5FUU 5FUU 5FUU 5FUU 5FUU 5FUU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU 5FU在CSCC中,CSCC是指CCCC.布莱莫辛 (Bleomycin) 是一种可怕的药物.癌症疫苗 癌症疫苗干扰子干扰子干扰子这是一个内部破裂.内溶性免疫疗法 免疫疗法甲基特雷克萨酸盐的使用方法型病毒 型病毒更多相关视频
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527


